Reporting owner · CIK 0001693548
Culverwell Anthony James
SEC Form 4 history across 1 companies, 3 transactions and 2 filings.
DIRQuoin Pharmaceuticals, Ltd.
Open-market transaction mix100% buys2 buys · 0 sales
Available history · Aug 27, 2026 – Aug 31, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
QNRXQuoin Pharmaceuticals, Ltd. | Culverwell Anthony JamesDIR | P · buyDerivative securitySEC filing ↗ | UnknownView disclosure → | |
QNRXQuoin Pharmaceuticals, Ltd. | Culverwell Anthony JamesDIR | P · buySEC filing ↗ | $29.9kView disclosure → | |
QNRXQuoin Pharmaceuticals, Ltd. | Culverwell Anthony JamesDIR | A · grantSEC filing ↗ | $161kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
buy at Quoin Pharmaceuticals, Ltd. on Aug 31, 2026 with an unknown reported value.
Review SEC filingLatest buy
buy at Quoin Pharmaceuticals, Ltd. on Aug 31, 2026 with an unknown reported value.
Review SEC filingLatest sale
No open-market insider sale is available.
Monthly open-market activity
Last 1 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 2 | 0 | — | $0.00 | — |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size—
Median P/S size—
Direct3
Indirect0
Aug 31, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
2 observations · Aug 27, 2026 – Aug 31, 2026. Window ends at the latest available report, not today.
Selected observation · Aug 31, 202640,364 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 27, 2026 | 34,218 | Aug 28, 2026 | View transaction |
| Aug 31, 2026 | 40,364 | Sep 2, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Culverwell Anthony James Insider Activity FAQ
SEC Form 4 context
Who is Culverwell Anthony James?
Culverwell Anthony James is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001693548.
Which companies has Culverwell Anthony James reported transactions for?
Quoin Pharmaceuticals, Ltd.
When was Culverwell Anthony James's latest insider buy?
buy at Quoin Pharmaceuticals, Ltd. on Aug 31, 2026 with an unknown reported value.
When was Culverwell Anthony James's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.